Sai Durga Life Sciences Inks Deal for Mellore Expansion Project

Sai Durga Life Sciences Private Limited is set to expand its operations with a new project in Mellore, Medak, Telangana. The focus of this initiative is the production of active pharmaceutical ingredients (APIs), essential components used in the manufacture of drugs. The facility is designed to have a significant output capacity, aiming to produce approximately 75 tons of APIs per month. This scale of production is indicative of the company's commitment to meeting the growing demands of the pharmaceutical industry, both domestically and internationally.

The strategic location of the facility in Mellore benefits from Telangana's strong pharmaceutical ecosystem, which includes robust supply chains, a skilled workforce, and supportive government policies promoting pharma sector growth. The region is known for its cluster of pharmaceutical companies, making it an ideal choice for Sai Durga Life Sciences to enhance its operational efficiencies and logistics.

The project not only focuses on the high-capacity production of APIs but also emphasizes adherence to stringent quality standards and environmental regulations. Sai Durga Life Sciences is dedicated to implementing cutting-edge technology and processes to ensure that the APIs are produced under the highest safety and quality guidelines. This commitment is crucial for the company's reputation and for ensuring the efficacy and safety of the final pharmaceutical products.

News by Rahul Yelligetti